Skip to content
logo with text
  • What we do
    • Scouting and Out-Licensing
    • Consulting to BD&L
    • Training
  • Current Projects
    • Topical Candidate for Eczema and Related Conditions
    • Custom Nanocomplex Formulation Opportunities
  • About Us
  • Contact
Menu
  • What we do
    • Scouting and Out-Licensing
    • Consulting to BD&L
    • Training
  • Current Projects
    • Topical Candidate for Eczema and Related Conditions
    • Custom Nanocomplex Formulation Opportunities
  • About Us
  • Contact

Reflections on BIO 2014

  • Post author:Carlos
  • Post published:July 2, 2014
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

    We're back and knee-deep in BIO2014 follow up work. Lacerta Bio was joined by 15,665 other "industry leaders" in days full of partnering discussions, pen-grabbing, eating and drinking, and…

Continue ReadingReflections on BIO 2014

Preparing for BIO Webinar

  • Post author:Carlos
  • Post published:May 13, 2014
  • Post category:Conferences
  • Post comments:0 Comments

This morning, Thompson Reuters and BIO presented a good webinar on preparing for BIO. I think it will be re-broadcast tomorrow.  A lot of time was spent on characterising transactions…

Continue ReadingPreparing for BIO Webinar

How was San Francisco?

  • Post author:Carlos
  • Post published:January 29, 2014
  • Post category:Conferences
  • Post comments:0 Comments

    We're still knee-deep in our follow up activities from the San Francisco conferences and receptions. Specifically, we spent the bulk of our time at the rapidly-growing Biotech Showcase…

Continue ReadingHow was San Francisco?

BIO Europe 2013 – Tying It All Together

  • Post author:Carlos
  • Post published:November 12, 2013
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

    We've returned from another successful BIO Europe conference, this time in Vienna. We regret not having much time to walk around in Vienna. However, this did not take away…

Continue ReadingBIO Europe 2013 – Tying It All Together

BIO Europe Preparation Video

  • Post author:Carlos
  • Post published:October 8, 2013
  • Post category:Conferences
  • Post comments:1 Comment

        Lacerta Bio is pleased to announce our participation in the 19th Annual BIO-Europe Conference in Vienna, Austria. As with last year's conference in Hamburg, this year's…

Continue ReadingBIO Europe Preparation Video

BIO2013: The Afterglow Edition

  • Post author:Carlos
  • Post published:April 30, 2013
  • Post category:Conferences
  • Post comments:0 Comments

    As we were making our way back home from Chicago (on delayed flights, of course), several things struck us about BIO2013. We've talked about BIO in the past.…

Continue ReadingBIO2013: The Afterglow Edition

ExcipientFest 2013

  • Post author:Carlos
  • Post published:April 26, 2013
  • Post category:Conferences
  • Post comments:0 Comments

    Now that we're back from BIO2013, we have to leave again!  We'll be at ExcipientFest 2013 in Baltimore for a few days. We'll be meeting with several Exhibitors,…

Continue ReadingExcipientFest 2013

Getting the Most out of BIO

  • Post author:Carlos
  • Post published:April 10, 2013
  • Post category:Conferences
  • Post comments:1 Comment

    Rob Wright has a really good article on preparing for BIO. In fact, it's applicable for just about any major conference or convention. You can read the entire…

Continue ReadingGetting the Most out of BIO

Tips for Attending Conferences

  • Post author:Carlos
  • Post published:February 28, 2013
  • Post category:Conferences
  • Post comments:0 Comments

As BD consultants, we attend a number of conferences, both large and small. Some have one-on-one meetings, some don't. Some are scientific conferences, while others are focused on partnering. As…

Continue ReadingTips for Attending Conferences

Observations from JPM 2013

  • Post author:Carlos
  • Post published:January 22, 2013
  • Post category:Conferences/Drug Development
  • Post comments:0 Comments

Lacerta Bio, along with approximately 10,000 other life science investors, executives, consultants, service providers, hangers-on, and many others, congregated in San Francisco for a variety of conferences, including the JP…

Continue ReadingObservations from JPM 2013
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Go to the next page

Recent Posts

  • GIGO: AI and Drug Candidate Valuation – Part V
  • The Platform Question: AI and Drug Candidate Valuation – Part IV
  • On Getting pAId: AI and Drug Candidate Valuation – Part III
  • Children And Crayons: AI and Drug Candidate Valuation – Part II
  • Clowns on a Stage

Archives

  • March 2026
  • February 2026
  • January 2026
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • June 2025
  • December 2024
  • October 2024
  • September 2024
  • April 2024
  • May 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • June 2022
  • March 2022
  • June 2021
  • February 2021
  • December 2020
  • September 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • June 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • May 2014
  • April 2014
  • February 2014
  • January 2014
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010

Categories

  • Artificial Intelligence
  • BD&L
  • Biosimilars
  • Biotech
  • Business Development/Licensing
  • China
  • Conferences
  • COVID-19
  • CRO
  • Diagnostics
  • Digital Health
  • Digital Medicine
  • Downsizing
  • Drug Delivery
  • Drug Development
  • Drug Discovery
  • Due Diligence
  • Emerging Markets
  • Entrepreneurship
  • Europe
  • Financing
  • Generics
  • Government
  • India
  • Marketing
  • Mergers & Acquisitions
  • Offshoring
  • Outsourcing
  • Pharmaceutical
  • Planning
  • Pricing
  • Reimbursement
  • Social Media
  • Tech Transfer
  • Uncategorized
  • Venture Capital

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Get in touch

To contact us, please email us at mail: info@lacertabio.com to schedule your free consultation, or call tele:+1 (845) 293-3343.